Digital Health: Future Promises vs Today’s Reality, April 4, 2016, Cham, Zug
Digital technologies have the potential to transform the healthcare sector, but in what ways and who will lead? Digital Health has already become a buzzword, but what is its real impact on the pharma and medtech sectors today? What are the lessons learnt from those already doing projects and implementations? If you are interested in Digital Health in any way, you will want to attend this evening discussion and expert panel. Tickets are free, but registration is required. We look forward to seeing you there.
New registrations only for waiting list due to strong demand. |
|
Lorenz Borer
Head Market Access & Compliance, Novartis Pharma Switzerland
Before taking up his current position in 2006, Lorenz Borer led Market Access/Business Development & Licensing. He started at Novartis as Corporate Affairs Manager. Before that, he held similar positions with Merck Sharp & Dohme (MSD) for nine years. He started his career at Grünenthal, a privately owned pharma company. He has a PhD from University of Bern, with an MSc in Molecular Biology. |
|
Dr Stephan Rietiker
CEO, LifeWatch
Serving as the CEO of cardiac monitoring startup Lifewatch since 2014, Stephan Rietiker also advises Brown Brothers Harriman’s Corporate Finance. Prior to that he founded AurigaVision, an investor in healthcare companies. Between 2001 and 2006 he led several medical device companies, including as CEO of Centerpulse (acquired by Zimmer in 2003), Pendragon and IMI Intelligent Medical Implants. From 1987 to 2001 he worked for Boehringer Mannheim and Schering Plough and Covance Central Laboratory Services. He has a PhD in Medicine from University of Zurich and is also licensed in the US. |
|
Michael Dillhyon
Founder, Healthbank
Michael is the founder of healthbank, and served as CEO until July 2014. In 2013, he was the first Entrepreneur-in-Residence for SystemsX.ch, Switzerland’s largest early stage life sciences fund, and served as a mentor for the ETH Innovation and Entrepreneurship Lab. Previously he served as Chairman of Genebio, a bioinformatics software firm, and sat on the Strategic Advisory Committee for HealthTIES, an EU-backed consortium of four of Europe’s top biosciences regions. Previous to his move to Switzerland, Michael co-founded two US-based firms: Netelligent Corporation and ActiveObjects, where he held the roles of President, Chairman and CEO respectively. |
|
Prof. Stefan Weber
Director and Chair Image-guided Therapies ARTORG Center for Biomedical Engineering, University Bern
In his current position since 2013, Stefan Weber leads a cutting edge laboratory working on surgical robotics and advanced imaging technologies, hearing and organ implants, cardiovascular and rehabilitation biomedical solutions. He has a PhD in Augmented Reality applications in medicine from the Humboldt-University in Berlin. |
|
Marc A. Weiss
Director, Multi-Channel Marketing
Bristol-Myers Squibb
Marc leads a group of specialized marketers within Bristol-Myers Squibb’s Customer Engagement Hub. They focus on critical communications to HCPs and Patients about Bristol-Myers Squibb’s Oncology products. His depth of experience includes brand and payer pharmaceutical marketing leadership in Oncology, Cardiovascular, and Transplant. Earlier in his career, Marc worked in Market Access for the University of Pennsylvania Health System, and at Health Partners Plans, a managed care organization for low-income patients. Marc holds an MBA in Health Administration from the Fox School of Business, Temple University. . |
|
Key Facts
When: Monday, April 4, 2016 18:00 to 20:00
Where: Bristol-Myers Squibb Hinterbergstrasse 16, Cham
Tickets: Sponsored by BMS
Registration
On Technologie Forum Zug website: www.technologieforumzug.ch/eventreg
Programme
18:00 Registration & Welcome Drink
18:30 Opening by Michelle Lock, VP and GM Bristol-Myers Squibb Switzerland and Austria, and Event Host
18:40 Speakers’ introductions and Panel Q&A
20:00 Refreshments and Networking
21:30 Close of event
INSEAD Alumni Association Switzerland
Aleks Ruzicic, MBA 97J, President cHIC
Chandra Leo, MBA 02D, Vice-President cHIC
insead@bluewin.ch |
|
|
